期刊文献+

穿膜肽的内化机制及其应用 被引量:8

Mechanism of Cell-penetrating Peptides-mediated Internalization and Its Application
下载PDF
导出
摘要 穿膜肽是一类具有特殊穿膜功能的多肽分子,能携带其它分子甚至超分子颗粒穿膜进入细胞内部.早期研究认为,其进胞是一种无需受体、也不存在饱和状态的非经典胞吞行为.近年研究表明,其穿膜机制可能与其含有的氨基酸种类有很大关系.现在,穿膜肽的穿膜过程称为巨型胞饮行为,它与传统的胞吞形式很相似.当然,还可能存在着其它的进胞方式而没有被证明或发现.关于穿膜肽的应用也是人们最感兴趣的,在很多领域的研究都在进行并不断取得进展.不论是生物界还是医学界,穿膜肽都被认为将是一类非常有发展潜力的多肽分子. Cell-penetrating peptides (CPPs) are short peptides of less than 30 amino acids and are able to penetrate cell membranes to transfer different cargoes into the cells. Internalized CPP cargoes range from small compounds to proteins and even supramolecular particles. In recent years, scientific studies have brought better understandings about the structures, biological properties, such as cytotoxicities, and internalization mechanisms of CPPs to penetrate membranes. CPPs are being developed into novel vehicles for cargo transportation into the cells, therefore, has been regarded as promising agents for drug delivery.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2008年第12期1092-1096,共5页 Chinese Journal of Biochemistry and Molecular Biology
关键词 穿膜肽 穿膜机制 应用 cell-penetrating peptide internalization mechanism application
  • 相关文献

参考文献37

  • 1Vives E. Present and future of cell-penetrating peptide mediated delivery systems:"is the trojan horse too wild to go only to troy? " [J]. J Control Release, 2005, 109(1-3): 77-85.
  • 2Hansen M, Kilk K, Langel U, et al. Predicting cell-penetrating peptides [J]. Adv Drug Deliv Rev, 2008, 60(4-5) : 572-579.
  • 3Green M, Loewenstein P M. Autonomous functional domains of chemically synthesized human immunodeficiency virus TAT transactivator protein [J]. Cell, 1988, 55(6): 1179-1188.
  • 4Green M, Ishino M, Loewenstein P M. Mutational analysis of HIV-1 TAT minimal domain peptides: identification of trans-domaint mutants that suppress HIV-LTR-driven gene expression[J]. Cell, 1989, 58 ( 1 ) :215-223.
  • 5Juliano R. Review of cell penetrating peptides: processes and applications[J]. J Control Release, 2003, 93(1): 88-89.
  • 6Zorko M, Langel U. Cell-penetrating peptides: mechanism and kinetics of cargo delivery [J]. Adv Drug Deliv Rev, 2005, 57(4) : 529-545.
  • 7Elmquist A, Hansen M, Langel U, Structure-activity relationship study of the cell-penetrating peptide pVEC [ J ]. Biochim Biophys Acta, 2006, 1758(6): 721-729.
  • 8Geisler I, Chmielewski J. Probing length effects and mechanism of cell penetrating agents mounted on a polyproline helix scaffold. [ J]. Bioorg Med Chem Lett, 2007, 17(10) : 2765- 2768.
  • 9Magzoub M, Eriksson L E, Graslund A. Comparison of the interaction, positioning, structure induction and membrane perturbation of cell-penetrating peptides and uon-translocating variants with phospholipid vesicles [J]. Biophys Chem, 2003, 103(3) : 271- 288.
  • 10Deshayes S, Plenat T, Charnet P, et al. Formation of transmembrane ionic channels of primary amphipathic cell-penetrating peptides. Consequences on the mechanism of cell penetration[J]. Biochim Biophys Acta, 2006, 1758(11) : 1846-1851.

二级参考文献32

  • 1王莉,吴玉章.穿膜肽研究展望[J].免疫学杂志,2001,17(z1):12-16. 被引量:2
  • 2刘秋英,张美英,罗新,李耘,邢少璟,王一飞,胡红梅.人脐静脉血管内皮细胞的体外培养及rhNDPK-A对其增殖的作用[J].中国卫生检验杂志,2005,15(3):257-258. 被引量:2
  • 3邢少璟,熊盛,张美英,李久香,王一飞.核苷二磷酸激酶A亚基(rhNDPK-A)对体内S_(180)、H_(22)、Lewis及H460肿瘤生长的影响[J].中国病理生理杂志,2006,22(9):1740-1743. 被引量:1
  • 4Porgador A, Yewdell JW, Deng Y, et al. Localization,quantitation, and in situ detection of specific peptide-MHC class Ⅰ complexes using a monoclonal antibody [ J ]. Immunity, 1997, 6 (6) : 715- 726.
  • 5Saric T, Beninga J, Graef CI, et al. Major histocompatibility complex class Ⅰ-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase [J]. J Biol Chem, 2001, 276 (39) : 36 474 - 36 481.
  • 6Schwarz K, de Giuli R, Schmidtke G, et al. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up-or down-regulate antigen presentation at nontoxic doses [J]. J Immunol, 2000, 164 (12): 6 147-6 157.
  • 7Mo XY, Cascio P, Lemerise K, et al. Distinct proteolytic processes generate the C and N termini of MHC class Ⅰ-binding peptides [J]. J Immunol, 1999, 163 (11): 5 851 -5 859.
  • 8Gavin MA,Torqerson TR,Rudensky AY,et al.Single-cell analysis of normal and FOXP3-mutant human T cells:FOXP3 expression without regulatory T cell development[J].Proc Natl Acad Sci USA,2006,103(17):6659-6664.
  • 9Hori S,Nomura T,Sakaguchi S.Control of regulatory T cell development by the transcription factor Foxp3[J] Science,2003,299(5609):1057-1061.
  • 10Liu Y,Li JL,Johnny JH.HIV-1 Tat protein-mediated transactivation of the HIV-1 long terminal repeat promoter is potentiated by a novel nuclear Tat-interacting protein of 110 kDa,tip110[J].J Biol Chem,2002,277(26):23854-23863.

共引文献8

同被引文献72

引证文献8

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部